Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & CofiledCriticalSearle & Co
Priority to CR7539ApriorityCriticalpatent/CR7539A/en
Publication of CR7539ApublicationCriticalpatent/CR7539A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
La presente invencion pertenece a una tableta con alta carga de farmaco, la cual comprende, como ingrediente activo, el Compuesto I de la Formula (I), o una sal farmaceuticamente aceptable del mismo, en una cantidad de aproximadamente el 30 por ciento al 80 por ciento en peso de la fraccion activa, basandose en el peso total de la tableta.The present invention pertains to a tablet with a high drug load, which comprises, as active ingredient, Compound I of Formula (I), or a pharmaceutically acceptable salt thereof, in an amount of about 30 percent to 80 weight percent of the active fraction, based on the total weight of the tablet.
CR7539A2004-10-212004-10-21
TABLET WITH HIGH CONTENT OF PHARMACOS
CR7539A
(en)
A PHARMACEUTICAL COMPOSITION THAT INCLUDES N- (3,4-DIFLUORO-2-4-IODOFENILAMINO) -6-METOXIFENIL) -L- (2,3-DIHIDROXIPROPIL) CICLOPROPANO-L-SULFONAMIDE, USEFUL FOR THE TREATMENT AND PREVENTION OF CANNER OF INFLAMMATORY DISEASES
Solid pharmaceutical preparation with delayed release comprising: a) a pharmaceutically active ingredient, b) 15 to 40% by weight of a mixture of polyvinylpyrrolidone and / or a derivative of polyvinylpyrrolidone and c) at least one diluent.